Anesthetic and Life Support Drugs Advisory Committee Food and Drug Administration; Department of Health and Human Services RE: Request for Formal Oral Presentation
نویسنده
چکیده
I am a board-certified anesthesiologist with an active practice at Brigham and Women’s Hospital in Boston, MA. I am familiar with the issues and challenges administering anesthesia and analgesia to neonates and young children. I am also Vice President of Medical Affairs at Aspect Medical Systems. Aspect manufactures a patient monitoring system which measures the effects of anesthetic agents in the brain. This system is currently used in the care of approximately 5 million adult and pediatric patients per year. We are collaborating and funding research on anesthesia outcomes in both children and adults.
منابع مشابه
A flood of opioids, a rising tide of deaths.
Faced with an epidemic of drug abuse and overdose deaths involving prescription opioid pain relievers, the Food and Drug Administration (FDA) plans to require opioid makers to provide training for physicians and patient-education materials on the appropriate prescribing and use of extendedrelease and long-acting versions of these drugs. But since July, FDA officials have been scrambling to revi...
متن کاملRoute of Drug Abuse and Its Impact on Oral Health-Related Quality of Life among Drug Addicts
Background: Various studies have tested quality of life (QOL) among drug addicts, however very few have reported any association between oral health-related quality of life (OHRQOL) and mode of drug administration among drug addicts. Hence, the present study was conducted aiming to evaluate the impact of mode of administration of drugs on OHRQOL among drug addicts. Methods: Data was collected u...
متن کاملDEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
The Food and Drug Administration (FDA, the Agency, or we) is issuing this final rule establishing that certain active ingredients used in nonprescription (also known as overthe-counter or OTC) antiseptic products intended for use by health care professionals in a hospital setting or other health care situations outside the hospital are not generally recognized as safe and effective (GRAS/GRAE)....
متن کاملDepartment of Health and Human Services Food and Drug Administration 21 Cfr Part 101 Food Labeling: Health Claims and Label Statements; Folic Acid and Neural Tube Defects
Agency: Food and Drug Administration, HHS. Action: Final Rule. __________________________ SUMMARY: The Food and Drug Administration (FDA) is announcing its decision not to authorize a health claim for folic acid and neural tube defects at this time. However, consistent with the recently announced recommendations of the U.S. Public Health Service (PHS) that all women of childbearing age in the U...
متن کاملO Food and Drug Administration Center for Drug Evaluation and Research
We are enclosing our written response to the Division of Neuropharmacological Drug Products position paper issued as Docket OON-0088 to support the upcoming March 9,200O Psychopharmacological Drugs Advisory Committee (PDAC) meeting. We are also following the procedures outlined in the Federal Register Notice of this PDAC meeting in order to make an oral presentation at the meeting. if you requi...
متن کامل